JHOP - June 2020 Vol 10, No 3

Savannah L. Gulley, PharmD; Kyle A. Franco, PharmD, BCPPS; Joshua J. Elder, PharmD, BCPS, BCOP

Venous Thromboembolism Management in Ambulatory Patients with Cancer: Dawn of the Oral Anticoagulant Era?

Sarah L. Hanson, PharmD; Christina Maher, PharmD; Jai N. Patel, PharmD, BCOP

Impact of Weight-Based Melphalan Dosing Strategies in Autologous Hematopoietic Stem-Cell Transplant for Multiple Myeloma

Erin K. Yeung, PharmD, BCPS; John Malamakal, PharmD, MS, BCPS, BCOP

Risk Factors for Subtherapeutic Tacrolimus Levels After Conversion from Intravenous to Oral Dosing Posttransplant in Adults

Kelsey Konrardy, PharmD; Kane Hosmer, PharmD, BCOP; Michelle Rockey, PharmD, BCOP, FHOPA; Zahra Mahmoudjafari, PharmD, BCOP; Dennis Grauer, MS, PhD; David Henry, MS, BCOP, FASHP; Leyla Shune, MD; Joseph McGuirk, DO

HOPA Abstracts

HOPA 2020 Abstracts

Symptom Management Overview

Direct Oral Anticoagulant Therapy for Heparin-Induced Thrombocytopenia—A New Alternative?

Zain Al-Jammali, PharmD; Harleen Singh, PharmD, BCACP; Joseph Bubalo, PharmD, BCOP; Joseph Shatzel, MD

HOPA Highlights

What’s New in the Oncology Drug Pipeline?

Meg Barbor, MPH

The Intersection of Immunotherapy and Targeted Therapy in Lung Cancer

Meg Barbor, MPH

The Cancer Care Gap in Rural America: A 50-Million People Conundrum

Meg Barbor, MPH